Evidence map›Paper›PMID 29459864›Full record

ArticleFrontiers in immunology2018

Blood CXCR3

Riddhima Banga, Francesco A Procopio, Alessandra Ruggiero, Alessandra Noto, Khalid Ohmiti, Matthias Cavassini, Jean-Marc Corpataux, William A Paxton, Georgios Pollakis, Matthieu Perreau

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 57 citations in OpenAlex.

  1. Dual CD8 and TCR editing in regulatory T cells mediates HLA-A2-restricted tissue-specific homing.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Contributions of Clinical Pharmacology to HIV Cure Research.Clinical pharmacology and therapeutics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Riddhima BangaService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Francesco A ProcopioService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Alessandra RuggieroDepartment of Clinical Infection, Microbiology and Immunology (CIMI), Institute of Infection and Global Health (IGH), University of Liverpool, Liverpool, United Kingdom.
Alessandra NotoService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Khalid OhmitiService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Matthias CavassiniInfectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Jean-Marc CorpatauxVascular Surgery, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
William A PaxtonDepartment of Clinical Infection, Microbiology and Immunology (CIMI), Institute of Infection and Global Health (IGH), University of Liverpool, Liverpool, United Kingdom.
Georgios PollakisDepartment of Clinical Infection, Microbiology and Immunology (CIMI), Institute of Infection and Global Health (IGH), University of Liverpool, Liverpool, United Kingdom.
Matthieu PerreauService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
University of Lausanne · CHUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently demonstrated that lymph nodes (LNs) PD-1

Indexed as

AdultAnti-Retroviral AgentsCD4-Positive T-LymphocytesDNA, ViralHIV-1HIV InfectionsHumansProgrammed Cell Death 1 ReceptorReceptors, CXCR3RNA, ViralVirus ReplicationAnti-Retroviral AgentsCXCR3 protein, humanDNA, ViralPDCD1 protein, humanProgrammed Cell Death 1 ReceptorReceptors, CXCR3RNA, Viralcirculating T follicular helper cell counterpartCXCR3lymph nodereplication competent virusT follicular helper cells

Identifiers

PMID29459864
PMCPMC5807378
OpenAlexW2795687485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.